Jump to content

GBR-13098

From Wikipedia, the free encyclopedia

This is an old revision of this page, as edited by The Nth User (talk | contribs) at 00:19, 5 August 2019 (→‎References: Replaced two categories with one subcategory). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

GBR-13098
Names
IUPAC name
1-{2-[Bis(4-fluorophenyl)methoxy]ethyl}-4-[3-(4-fluorophenyl)propyl]piperazine
Identifiers
3D model (JSmol)
ChemSpider
  • InChI=1S/C28H31F3N2O/c29-25-9-3-22(4-10-25)2-1-15-32-16-18-33(19-17-32)20-21-34-28(23-5-11-26(30)12-6-23)24-7-13-27(31)14-8-24/h3-14,28H,1-2,15-21H2
    Key: OEZGWIMXRXRLRR-UHFFFAOYSA-N
  • InChI=1/C28H31F3N2O/c29-25-9-3-22(4-10-25)2-1-15-32-16-18-33(19-17-32)20-21-34-28(23-5-11-26(30)12-6-23)24-7-13-27(31)14-8-24/h3-14,28H,1-2,15-21H2
    Key: OEZGWIMXRXRLRR-UHFFFAOYAF
  • C1CN(CCN1CCCC2=CC=C(C=C2)F)CCOC(C3=CC=C(C=C3)F)C4=CC=C(C=C4)F
Properties
C28H31F3N2O
Molar mass 468.564 g·mol−1
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).

GBR-13098 is a psychostimulant and selective dopamine uptake inhibitor.[1]

Blocking the endogenous striatal dopamine (DA) transporter with GBR-13098 in mice has been shown to prevent damage to the DA nerve terminals caused by malonate. It was suggested that DA transporter inhibitors like GBR-13098 could be used to prevent or treat neurodegenerative disorders caused by the effect of mitochondrial dysfunction on DA homeostasis.[2]

See also

References

  1. ^ Pileblad E, and Engberg G. (Dec 1986). "GBR 13098, a selective dopamine uptake inhibitor; behavioural, biochemical and electrophysiological studies". Naunyn Schmiedebergs Arch Pharmacol. 334 (4): 383–7. PMID 2950328.
  2. ^ Moy LY; et al. (Feb 2007). "Mitochondrial stress-induced dopamine efflux and neuronal damage by malonate involves the dopamine transporter". J Pharmacol Exp Ther. 320 (2): 747–56. doi:10.1124/jpet.106.110791. PMID 17090704.